CNC

SELL

Centene Corporation

Healthcare · Rank #456 · Analyzed Oct 18, 2026

$69.16

Current Price

$5.00

Intrinsic Value

-92.8%

Upside/Downside

1/10

Score

1/5

Quality

Analysis Summary

Valuation Consensus0/2 methods agree

Quality Score1/5.0

Framework RatingSELL

Price vs Intrinsic ValueOvervalued by 92.8%

Fair Value Range

Low$2.40

Base (IV)$5.00

High$7.60

Entry Points

Conservative$1.68

Moderate$2.40

Aggressive$3.50

⚠️ Warnings

DCF discarded: negative profit margins

Quality & Moat Breakdown

Return on Equity-20.4% → 0/1.0

Debt LevelD/E 71 → 0/1.0

Revenue QualityGrowth 23.7%, margin Δ-3.8% +recovery → 1.0/1.0

Moat Strength1.5/5 → 0/1.0

Profit Margins-2.8% → 0/1.0

Methodology

This analysis uses a unified valuation framework combining three methods, Discounted Cash Flow (3-scenario), Earnings Power Value, and Asset Valuation, with a quality scoring overlay. A stock needs 2/3 valuation methods to agree and a quality score ≥ 3.5/5 for a BUY rating.

Learn how this framework works →

This is a personal analysis tool, not financial advice. Do your own research before making investment decisions.